| Financial Year |
March 31 2023 |
| Monetary Funds |
3,620,570,860.46 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
520,458,277.75 |
| Advances to Suppliers |
275,780,759.59 |
| Other Receivables |
23,549,110.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
704,697,314.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,537,205.00 |
| Other Current Assets |
2,717,113,729.76 |
| Total Current Assets |
7,916,155,474.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
460,532,832.86 |
| Investment Properties |
156,401,836.42 |
| Fixed Assetes |
899,437,537.51 |
| Under-construction Projects |
320,536,817.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
724,089,054.56 |
| R&D expenses |
16,029,838.55 |
| Goodwill |
1,117,851,067.38 |
| Long-Term Deferred and Prepaid Expenses |
1,501,590.17 |
| Deferred Income Tax Assets |
256,439,725.64 |
| Other Non-Current Assets |
1,073,015,875.14 |
| Sub-Total of Non-Current Assets |
5,719,318,916.45 |
| Total Assets |
13,635,474,391.00 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
341,253,805.36 |
| Accounts Received In Advance |
102,402.15 |
| Employee Compensation Payable |
112,909,967.70 |
| Taxes Payable |
289,945,068.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
453,684,882.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,758,991.65 |
| Other Current Liabilities |
10,019,604.66 |
| Sub-Total of Current Liabilities |
1,607,038,842.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
184,949,792.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
271,157,475.93 |
| Total Liabilities |
1,878,196,318.35 |
| Paid-In Capital(Or Share Stock) |
1,700,467,763.00 |
| Capital Surplus |
6,115,234,557.48 |
| Surplus Reserve |
852,562,906.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,161,989,031.30 |
| Minority Stockholder's Interest |
83,356,120.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,673,921,952.14 |
| Owner's Equity（Stockholder's Equity） |
11,757,278,072.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,635,474,391.00 |
